(VIANEWS) – Horizon Technology Finance Corporation (HRZN), JinkoSolar Holding Company Limited (JKS), Esquire Financial Holdings (ESQ) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Horizon Technology Finance Corporation (HRZN)
71.4% sales growth and 7.11% return on equity
Horizon Technology Finance Corporation is a business development company specializing in lending and and investing in development-stage investments. It focuses on making secured debt and venture lending investments to venture capital backed companies in the technology, life science, healthcare information and services, and cleantech industries. It seeks to invest in companies in the United States.
Earnings Per Share
As for profitability, Horizon Technology Finance Corporation has a trailing twelve months EPS of $0.72.
PE Ratio
Horizon Technology Finance Corporation has a trailing twelve months price to earnings ratio of 17.54. Meaning, the purchaser of the share is investing $17.54 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 7.11%.
Yearly Top and Bottom Value
Horizon Technology Finance Corporation’s stock is valued at $12.61 at 19:22 EST, way below its 52-week high of $15.85 and way above its 52-week low of $9.67.
Volume
Today’s last reported volume for Horizon Technology Finance Corporation is 199361 which is 0.69% below its average volume of 200749.
Sales Growth
Horizon Technology Finance Corporation’s sales growth is 56.7% for the current quarter and 71.4% for the next.
2. JinkoSolar Holding Company Limited (JKS)
37.7% sales growth and 4.4% return on equity
JinkoSolar Holding Co., Ltd., together with its subsidiaries, engages in the design, development, production, and marketing of photovoltaic products. The company offers solar modules, silicon wafers, solar cells, recovered silicon materials, and silicon ingots. It also provides solar system integration services; and develops commercial solar power projects. The company sells its products to distributors, project developers, and system integrators; and utility, commercial, and residential customers under the JinkoSolar brand, as well as on an original equipment manufacturer basis. As of December 31, 2019, it had an integrated annual capacity of 15.0 gigawatt (GW) for silicon wafers, including 11.5 GW for mono wafers; 10.6 GW for solar cells; and 16.0 GW for solar modules. The company has operations in the People's Republic of China, the United States, Japan, Germany, the United Kingdom, Chile, South Africa, India, Mexico, Brazil, the United Arab Emirates, Italy, Spain, France, Belgium, and internationally. JinkoSolar Holding Co., Ltd. was founded in 2006 and is based in Shangrao, the People's Republic of China.
Earnings Per Share
As for profitability, JinkoSolar Holding Company Limited has a trailing twelve months EPS of $0.46.
PE Ratio
JinkoSolar Holding Company Limited has a trailing twelve months price to earnings ratio of 109.76. Meaning, the purchaser of the share is investing $109.76 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.4%.
Earnings Before Interest, Taxes, Depreciation, and Amortization
JinkoSolar Holding Company Limited’s EBITDA is 8.01.
Yearly Top and Bottom Value
JinkoSolar Holding Company Limited’s stock is valued at $50.49 at 19:22 EST, way below its 52-week high of $76.92 and way above its 52-week low of $35.41.
3. Esquire Financial Holdings (ESQ)
37.3% sales growth and 18.29% return on equity
Esquire Financial Holdings, Inc. operates as the bank holding company for Esquire Bank, National Association that provides commercial banking products and services to legal industry and small businesses, and commercial and retail customers in the United States. The company offers checking, savings, money market, and time deposits, as well as certificates of deposit. It also provides commercial loans, including short-term financing for inventory, receivables, the purchase of supplies, or other operating needs arising during the normal course of business, as well as loans to its qualified merchant customers; commercial lines of credit; consumer loans consisting of post-settlement consumer and structured settlement loans to plaintiffs and claimants, as well as loans to individuals for debt consolidation, medical expenses, living expenses, payment of outstanding bills, or other consumer needs; and real estate loans, such as multifamily, 1-4 family residential, commercial real estate, and construction loans, as well as merchant services. As of December 31, 2020, the company operated a full-service branch in Jericho, New York; and an administrative office in Boca Raton, Florida. Esquire Financial Holdings, Inc. was founded in 2006 and is headquartered in Jericho, New York.
Earnings Per Share
As for profitability, Esquire Financial Holdings has a trailing twelve months EPS of $1.86.
PE Ratio
Esquire Financial Holdings has a trailing twelve months price to earnings ratio of 24.14. Meaning, the purchaser of the share is investing $24.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 18.29%.
4. Travelzoo (TZOO)
23% sales growth and 15.85% return on equity
Travelzoo, an Internet media company, provides travel, entertainment, and local deals from travel and entertainment companies, and local businesses in the Asia Pacific, Europe, and North America. Its publications and products include Travelzoo Website; Travelzoo iPhone and Android apps; Travelzoo Top 20 email newsletter; and Newsflash email alert service. The company also operates the Travelzoo Network, a network of third-party Websites that list travel deals published by the company; and Local Deals and Getaway listings, which allow its members to purchase vouchers for deals from local businesses, such as spas, hotels, and restaurants. It serves airlines, hotels, cruise lines, vacations packagers, tour operators, destinations, car rental companies, travel agents, theater and performing arts groups, restaurants, spas, and activity companies. Travelzoo Inc. was founded in 1998 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, Travelzoo has a trailing twelve months EPS of $-0.75.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.85%.
Previous days news about Travelzoo(TZOO)
- According to Zacks on Wednesday, 1 March, "One other stock from the same industry, Travelzoo (TZOO Quick QuoteTZOO – Free Report) , is yet to report results for the quarter ended December 2022."
5. DexCom (DXCM)
18.9% sales growth and 9.19% return on equity
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM system for diabetes management; Dexcom Real-Time API, which enables invited third-party developers to integrate real-time CGM data into their digital health applications and devices; Dexcom ONE, that is designed to replace finger stick blood glucose testing for diabetes treatment decisions; and Dexcom Share, a remote monitoring system. The company's products candidature comprises Dexcom G7, a next generation G7 CGM system. DexCom, Inc. has a collaboration and license agreement with Verily Life Sciences LLC and Verily Ireland Limited to develop blood-based or interstitial glucose monitoring products. The company markets its products directly to endocrinologists, physicians, and diabetes educators. DexCom, Inc. was incorporated in 1999 and is headquartered in San Diego, California.
Earnings Per Share
As for profitability, DexCom has a trailing twelve months EPS of $5.2.
PE Ratio
DexCom has a trailing twelve months price to earnings ratio of 21.29. Meaning, the purchaser of the share is investing $21.29 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.19%.
Moving Average
DexCom’s value is under its 50-day moving average of $111.32 and way above its 200-day moving average of $95.62.
6. Corcept Therapeutics Incorporated (CORT)
14.1% sales growth and 23.06% return on equity
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and psychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, who have type 2 diabetes mellitus or glucose intolerance, and have failed surgery or are not candidates for surgery. It is developing relacorilant to treat patients with Cushing's syndrome; and nab-paclitaxel in combination with relacorilant, which has completed Phase II clinical trial to treat patients with serous ovarian tumors, as well as in Phase III clinical trial for the treatment of solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated was founded in 1998 and is headquartered in Menlo Park, California.
Earnings Per Share
As for profitability, Corcept Therapeutics Incorporated has a trailing twelve months EPS of $0.99.
PE Ratio
Corcept Therapeutics Incorporated has a trailing twelve months price to earnings ratio of 21.53. Meaning, the purchaser of the share is investing $21.53 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.06%.
Sales Growth
Corcept Therapeutics Incorporated’s sales growth is 6.3% for the ongoing quarter and 14.1% for the next.
Previous days news about Corcept Therapeutics Incorporated(CORT)
- According to Zacks on Wednesday, 1 March, "Corcept Therapeutics Incorporated price-consensus-chart | Corcept Therapeutics Incorporated Quote"
7. Kirby Corporation (KEX)
10.8% sales growth and 4.19% return on equity
Kirby Corporation operates domestic tank barges in the United States. Its Marine Transportation segment provides marine transportation services and towing vessels transporting bulk liquid products, as well as operates tank barges throughout the Mississippi River System, on the Gulf Intracoastal Waterway, coastwise along three United States coasts, and in Alaska and Hawaii. This segment also transports petrochemicals, black oil, refined petroleum products, and agricultural chemicals by tank barges; and operates offshore dry-bulk barge and tugboat units that are engaged in the offshore transportation of dry-bulk cargoes in the United States coastal trade. As of December 31, 2019, this segment owned and operated 1,053 inland tank barges with 23.4 million barrels of capacity, 299 inland towboats, 49 coastal tank barges with 4.7 million barrels of capacity, 47 coastal tugboats, 4 offshore dry-bulk cargo barges, 4 offshore tugboats, and 1 docking tugboat. The company's Distribution and Services segment sells replacement parts; provides service mechanics to overhaul and repair engines, transmissions, reduction gears, and related oilfield services equipment; rebuilds component parts or diesel engines, transmissions and reduction gears, and related equipment used in oilfield services, marine, power generation, on-highway, and other industrial applications; rents industrial compressors, railcar movers, and high capacity lift trucks; and manufactures and remanufactures oilfield service equipment, including pressure pumping units. It serves oilfield service, on-highway transportation, marine transportation, commercial fishing, construction, and power generation companies, as well as oil and gas operators and producers, and the United States government. The company was formerly known as Kirby Exploration Company, Inc. and changed its name to Kirby Corporation in 1990. Kirby Corporation was founded in 1921 and is headquartered in Houston, Texas.
Earnings Per Share
As for profitability, Kirby Corporation has a trailing twelve months EPS of $2.01.
PE Ratio
Kirby Corporation has a trailing twelve months price to earnings ratio of 35.37. Meaning, the purchaser of the share is investing $35.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.19%.
Yearly Top and Bottom Value
Kirby Corporation’s stock is valued at $71.09 at 19:22 EST, under its 52-week high of $75.08 and way higher than its 52-week low of $55.03.
Revenue Growth
Year-on-year quarterly revenue growth grew by 23.5%, now sitting on 2.78B for the twelve trailing months.
Volume
Today’s last reported volume for Kirby Corporation is 74158 which is 80.48% below its average volume of 379915.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter and the next is 120.7% and 80.9%, respectively.
